Harousseau J L, Andrieu J M, Dumont J, Montagnon B, Asselain B, Daniel M T, Flandrin G
Nouv Presse Med. 1980 Dec 6;9(46):3513-6.
Five cases of acute myeloblastic leukaemia (AML) arising in the course of non-Hodgkin's lymphoma (NHL) are described. The initial lymphoma was nodular lymphoid poorly differentiated in 4 cases. All patients were under chemotherapy for at least 28 months, and 3 of them were irradiated. AML was diagnosed 44 to 78 months after NHL and was heralded in 3 cases by a preleukaemia phase of pancytopenia. The leukaemia was typically myeloblastic in 2 cases and difficult to classify in 3 cases. Death occurred rapidly in 4 patients. The actuarial risk was 4.5% at 5 years. Since AML's occur mainly in NHL's, the management of this type of lymphoma with favourable prognosis ought to be reevaluated.
本文描述了5例在非霍奇金淋巴瘤(NHL)病程中发生的急性髓细胞白血病(AML)。4例患者最初的淋巴瘤为结节性低分化淋巴细胞型。所有患者均接受了至少28个月的化疗,其中3例还接受了放疗。AML在NHL发病44至78个月后被诊断出来,3例患者在白血病前期出现全血细胞减少。2例患者的白血病典型为髓细胞性,3例难以分类。4例患者迅速死亡。5年的精算风险为4.5%。由于AML主要发生在NHL中,对于这种预后良好的淋巴瘤类型的治疗应该重新评估。